• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类黑色素瘤细胞系中N-ras的激活。

Activation of N-ras in a human melanoma cell line.

作者信息

Padua R A, Barrass N C, Currie G A

出版信息

Mol Cell Biol. 1985 Mar;5(3):582-5. doi: 10.1128/mcb.5.3.582-585.1985.

DOI:10.1128/mcb.5.3.582-585.1985
PMID:3887133
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC366752/
Abstract

DNA isolated from cell line Mel Swift, a human melanoma cell line, transforms NIH3T3 cells. Southern blot analysis of DNA from secondary foci revealed conserved 8.8- and 7.8-kilobase EcoRI fragments which hybridized with a human repetitive sequence clone, blur 8. The activated transforming gene was identified as N-ras, and the 8.8-kilobase EcoRI fragment from a secondary transformant was cloned. Synthetic 17-mer oligonucleotides which spanned either the normal codon 61 (CAA) or a mutant codon 61 (AAA) were used for hybridization. Cloned N-ras from melanoma cell line Mel Swift hybridized to the mutant (AAA) oligonucleotide. From this we predicted a glutamine-to-lysine substitution in amino acid 61, a change confirmed by conventional sequencing of the first and second exons of N-ras from cell line Mel Swift. Transfection experiments showed that only those recombinant clones with the mutation in position 61 were biologically active.

摘要

从人黑色素瘤细胞系Mel Swift分离得到的DNA可转化NIH3T3细胞。对二代集落的DNA进行Southern印迹分析,发现了与人类重复序列克隆blur 8杂交的8.8千碱基和7.8千碱基的保守EcoRI片段。激活的转化基因被鉴定为N-ras,并克隆了来自二代转化体的8.8千碱基EcoRI片段。使用跨越正常密码子61(CAA)或突变密码子61(AAA)的合成17聚体寡核苷酸进行杂交。来自黑色素瘤细胞系Mel Swift的克隆N-ras与突变(AAA)寡核苷酸杂交。由此我们预测氨基酸61处谷氨酰胺被赖氨酸取代,这一变化通过对细胞系Mel Swift的N-ras第一和第二外显子进行常规测序得到证实。转染实验表明,只有那些第61位发生突变的重组克隆具有生物学活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c67b/366752/af17b0f4b45b/molcellb00099-0161-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c67b/366752/af17b0f4b45b/molcellb00099-0161-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c67b/366752/af17b0f4b45b/molcellb00099-0161-a.jpg

相似文献

1
Activation of N-ras in a human melanoma cell line.人类黑色素瘤细胞系中N-ras的激活。
Mol Cell Biol. 1985 Mar;5(3):582-5. doi: 10.1128/mcb.5.3.582-585.1985.
2
Molecular cloning and the total nucleotide sequence of the human c-Ha-ras-1 gene activated in a melanoma from a Japanese patient.在一名日本患者黑色素瘤中激活的人c-Ha-ras-1基因的分子克隆及全核苷酸序列
Proc Natl Acad Sci U S A. 1984 Aug;81(15):4771-5. doi: 10.1073/pnas.81.15.4771.
3
Both N-ras and c-myc are activated in the SHAC human stomach fibrosarcoma cell line.在SHAC人胃纤维肉瘤细胞系中,N-ras和c-myc均被激活。
Int J Cancer. 1988 May 15;41(5):732-7. doi: 10.1002/ijc.2910410516.
4
Transforming activity of human melanoma DNA.人类黑色素瘤DNA的转化活性
Gan. 1983 Dec;74(6):794-7.
5
Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation.需要突变来激活p53基因,以便与ras癌基因协同作用并实现转化。
J Virol. 1989 Feb;63(2):739-46. doi: 10.1128/JVI.63.2.739-746.1989.
6
Biochemical and biological activities of N-ras proteins.N-ras蛋白的生化及生物学活性
Biochem Biophys Res Commun. 1986 Sep 14;139(2):771-9. doi: 10.1016/s0006-291x(86)80057-2.
7
Activation of a human c-K-ras oncogene.人类c-K-ras癌基因的激活。
Nucleic Acids Res. 1984 Dec 11;12(23):8873-85. doi: 10.1093/nar/12.23.8873.
8
Activation of N-ras induced by ultraviolet irradiation in vitro.体外紫外线照射诱导N-ras激活。
Oncogene Res. 1988;3(1):9-20.
9
A novel transforming gene in a human malignant melanoma cell line.
Nature. 1984;311(5987):671-3. doi: 10.1038/311671a0.
10
Isolation of transforming sequences of two human lung carcinomas: structural and functional analysis of the activated c-K-ras oncogenes.两例人肺癌转化序列的分离:活化的c-K-ras癌基因的结构与功能分析
Proc Natl Acad Sci U S A. 1984 Jan;81(1):71-5. doi: 10.1073/pnas.81.1.71.

引用本文的文献

1
Novel insights into the pathogenesis and treatment of NRAS mutant melanoma.NRAS 突变型黑色素瘤发病机制与治疗的新见解。
Expert Rev Precis Med Drug Dev. 2021;6(4):281-294. doi: 10.1080/23808993.2021.1938545. Epub 2021 Aug 11.
2
[Molecular and immunohistochemical diagnostics in melanoma].[黑色素瘤的分子与免疫组化诊断]
Hautarzt. 2016 Jul;67(7):511-8. doi: 10.1007/s00105-016-3807-1.
3
A novel multi-CDK inhibitor P1446A-05 restricts melanoma growth and produces synergistic effects in combination with MAPK pathway inhibitors.

本文引用的文献

1
Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change.T24膀胱癌转化基因的激活与单个氨基酸变化有关。
Nature. 1982 Dec 23;300(5894):762-5. doi: 10.1038/300762a0.
2
Oncogenes in solid human tumours.人类实体瘤中的癌基因。
Nature. 1982 Dec 9;300(5892):539-42. doi: 10.1038/300539a0.
3
A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene.一个点突变导致了T24人膀胱癌癌基因获得转化特性。
一种新型多周期蛋白依赖性激酶(CDK)抑制剂P1446A-05可抑制黑色素瘤生长,并与丝裂原活化蛋白激酶(MAPK)信号通路抑制剂联合使用时产生协同效应。
Cancer Biol Ther. 2016 Jul 2;17(7):778-84. doi: 10.1080/15384047.2016.1139267.
4
Melanoma: oncogenic drivers and the immune system.黑色素瘤:致癌驱动因素与免疫系统
Ann Transl Med. 2015 Oct;3(18):265. doi: 10.3978/j.issn.2305-5839.2015.08.06.
5
The dual RAF/MEK inhibitor CH5126766/RO5126766 may be a potential therapy for RAS-mutated tumor cells.双重RAF/MEK抑制剂CH5126766/RO5126766可能是RAS突变肿瘤细胞的一种潜在治疗方法。
PLoS One. 2014 Nov 25;9(11):e113217. doi: 10.1371/journal.pone.0113217. eCollection 2014.
6
Melanoma: new insights and new therapies.黑素瘤:新的认识和新的治疗方法。
J Invest Dermatol. 2012 Mar;132(3 Pt 2):854-63. doi: 10.1038/jid.2011.421. Epub 2012 Jan 5.
7
Molecular bases of cutaneous and uveal melanomas.皮肤和葡萄膜黑色素瘤的分子基础。
Patholog Res Int. 2011;2011:159421. doi: 10.4061/2011/159421. Epub 2011 Aug 18.
8
Combinatorial treatments that overcome PDGFRβ-driven resistance of melanoma cells to V600EB-RAF inhibition.联合治疗方案可克服黑色素瘤细胞对 V600EB-RAF 抑制的 PDGFRβ 驱动耐药性。
Cancer Res. 2011 Aug 1;71(15):5067-74. doi: 10.1158/0008-5472.CAN-11-0140.
9
Measurement of constitutive MAPK and PI3K/AKT signaling activity in human cancer cell lines.人癌细胞系中组成型MAPK和PI3K/AKT信号传导活性的测定。
Methods Enzymol. 2010;484:549-67. doi: 10.1016/B978-0-12-381298-8.00027-7.
10
Analysis of the genome to personalize therapy for melanoma.对黑色素瘤进行个体化治疗的基因组分析。
Oncogene. 2010 Oct 14;29(41):5545-55. doi: 10.1038/onc.2010.323. Epub 2010 Aug 9.
Nature. 1982 Nov 11;300(5888):149-52. doi: 10.1038/300149a0.
4
Acquisition of transforming properties by alternative point mutations within c-bas/has human proto-oncogene.c-bas/has人类原癌基因内的替代点突变导致转化特性的获得。
Nature. 1983 Jun 30;303(5920):775-9. doi: 10.1038/303775a0.
5
Predicted nucleotide-binding properties of p21 protein and its cancer-associated variant.p21蛋白及其癌症相关变体的预测核苷酸结合特性。
Nature. 1983 Apr 28;302(5911):842-4. doi: 10.1038/302842a0.
6
Transforming ras genes from human melanoma: a manifestation of tumour heterogeneity?来自人类黑色素瘤的转化型ras基因:肿瘤异质性的一种表现?
Nature. 1984;308(5954):69-72. doi: 10.1038/308069a0.
7
The HL-60 transforming sequence: a ras oncogene coexisting with altered myc genes in hematopoietic tumors.HL-60转化序列:一种与造血肿瘤中改变的myc基因共存的ras癌基因。
Cell. 1983 Jul;33(3):749-57. doi: 10.1016/0092-8674(83)90017-x.
8
Localisation of the human N-ras oncogene to chromosome 1cen - p21 by in situ hybridisation.通过原位杂交将人类N-ras癌基因定位到染色体1cen - p21。
EMBO J. 1983;2(12):2281-3. doi: 10.1002/j.1460-2075.1983.tb01735.x.
9
Structure and activation of the human N-ras gene.人类N-ras基因的结构与激活
Cell. 1983 Sep;34(2):581-6. doi: 10.1016/0092-8674(83)90390-2.
10
Autophosphorylation of v-Ha-ras p21 is modulated by amino acid residue 12.v-Ha-ras p21的自磷酸化受氨基酸残基12的调控。
Proc Natl Acad Sci U S A. 1984 May;81(9):2674-8. doi: 10.1073/pnas.81.9.2674.